November 20, 2026
Uncategorized

Delhi HC allows Zydus to sell, mkt generic version of cancer drug nivolumab (Soban News)

The Delhi High Court has allowed Zydus Lifesciences to sell its nivolumab biosimilar, citing public interest, while directing the firm to maintain audited sales accounts pending the patent case​The Delhi High Court has allowed Zydus Lifesciences to sell its nivolumab biosimilar, citing public interest, while directing the firm to maintain audited sales accounts pending the patent case ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Himachal has adequate petrol, diesel and LPG stocks, says chief secretary (Soban News)

News-Soban-Admin

Silver price prediction: Analyst explains why chasing rally may be risky (Soban News)

News-Soban-Admin

Manappuram Finance surges 12% in 2 days, nears 52-week high; here’s why (Soban News)

News-Soban-Admin

Leave a Comment